Francis Medical Launches with $18M Series A Funding for Promising Cancer Ablation Technology Using Water Vapor Arboretum Ventures, H2Oey Ventures, Tonkawa and Boston Scientific lead financing of innovative, proprietary cancer therapies MINNEAPOLIS, December 13, 2018-- Francis Medical, Inc., a Minneapolis-based, privately held medical device company developing an innovative and proprietary vapor ablation therapy to treat a variety of endourology cancers, beginning with Prostate Cancer (PCa), today announced the completion of a $18.0 million round of Series A financing. Arboretum Ventures led the Series A with co-investments from H2Oey Ventures, an affiliate of Solas BioVentures Fund, Tonkawa and Boston Scientific.